Active Case Treatment Lebih Cost Effective untuk Pengobatan TB Paru Tahap Awal
ABSTRACT: The magnitude of
lung TB problem has forced any involved-institutions to be committed in
managing thoroughly. It is compulsory to have a correct intervention or
accurate treatment regime for curative purposes. Jember Regency is executing
Passive Case Treatment (PCT), which lung TB patients should come to puskesmas
to take the Tuberculosis Drug (ATD) in a certain day and hour. The method was
not effective, an idea to create an ATD delivery to patients’ homes was
executed, it is called Active Case Treatment (ACT). The purpose of this
research is to determine the most cost effective between PCT and ACT for lung
TB patients using a quasy experimental research with prospective plan of 16 Puskesmas
in Jember Regency. Conducted from beginning of September until end of November
2010, the sample was all lung TB patients who came for treatment in September
2010. Sample criteria were: new case, 15–50 years of age, did not suffer HIV
and Diabetes Mellitus, was not malnourished, and was not allergic to ATD. Data
collection was done through interview, questionnaires and filling documents
exploration. Research result is achieved by comparing total cost with program
objective (QoL= quality of life) of each treatment. The result showed that to
increase 1 QoL scale of PCT needed an amount of IDR. 35,295.00, while to
increase 1 QoL scale ACT was IDR 14,377.00. The cost of ACT was smaller than
PCT. Conclusion derived from the result was that ACT is more cost effective
than PCT.
Penulis: NI KETUT ARDANI
Kode Jurnal: jpkesmasdd120032